Company Profile

Zimmer Biomet Stock Price, News & Analysis

Ticker:
ZBH
Exchange:
NYSE
Sector:
MedTech
Location:
United States

Stock performance

97.19 USD (-0.99%)

Close

Last updated: August 6, 2026

16.2B USD

Market cap

Why the stock is moving

As of Aug 6, 2026, ZBH closed down 0.99% at $97.19. No new same-company headline was identified in the current news window.

Company overview

Business overview

Zimmer Biomet is a medical technology company focused on orthopedics, joint replacement, and musculoskeletal solutions. Its business is tied to procedure volumes and the adoption of implant and surgical systems.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NYSE, Zimmer Biomet has a global orthopedic footprint. It is a medtech company rather than a biotech name.

Business Model Characteristics

The business generates revenue through implants, surgical systems, and procedure-linked products. Investors watch joint-replacement demand, surgical volumes, product launches, and margin recovery.

Position Within the Biotechnology Landscape

Zimmer Biomet sits outside biotech but inside the broader healthcare technology stack. It is influenced by procedure trends and device adoption, not by drug approvals or clinical readouts.

Future catalysts

Zimmer Biomet should be watched for ROSA robotics adoption, hip and knee procedure growth, and continued product-cycle execution. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.

Recent news

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Zimmer Biomet (ZBH)?

    Zimmer Biomet (ZBH) most recently closed at 97.19 USD, a -0.99% move versus the previous session.

    What is the market cap of Zimmer Biomet (ZBH)?

    Zimmer Biomet currently has a market capitalization of 16.2B USD on BioPharmSignal.

    What does Zimmer Biomet do?

    Zimmer Biomet is a medical technology company focused on orthopedics, joint replacement, and musculoskeletal solutions. Its business is tied to procedure volumes and the adoption of implant and surgical systems.

    On which exchange is ZBH stock listed?

    Zimmer Biomet (ZBH) is associated with NYSE, United States, MedTech.

    What is Zimmer?

    Zimmer Biomet should be watched for ROSA robotics adoption, hip and knee procedure growth, and continued product-cycle execution.

    Which conditions is Zimmer Biomet targeting with Zimmer?

    Zimmer Biomet should be watched for ROSA robotics adoption, hip and knee procedure growth, and continued product-cycle execution.

    How does Zimmer Biomet describe recent progress with Zimmer?

    Zimmer Biomet should be watched for ROSA robotics adoption, hip and knee procedure growth, and continued product-cycle execution.

    What is Biomet?

    Zimmer Biomet is a medical technology company focused on orthopedics, joint replacement, and musculoskeletal solutions.